Literature DB >> 28869468

Association of Gait Speed, Psychomotor Speed, and Dementia.

Callixte Kuate-Tegueu1, José-Alberto Avila-Funes2,3, Nadine Simo4, Mélanie Le Goff3,5, Hélène Amiéva3,5, Jean-François Dartigues3,5, Maturin Tabue-Teguo4,3,5,6.   

Abstract

BACKGROUND: Gait speed (GS) and psychomotor speed (PS) could be considered as two different dimensions of age-related slowness and both measures are associated with higher risk of adverse health-related outcomes among elderly people.
OBJECTIVE: To determine the association between GS, PS, and incident dementia among community-dwelling older adults.
METHODS: Twelve-year longitudinal study of 1,265 participants in the Bordeaux Three-City Study, a French prospective cohort designed to determine the risk of dementia and cognitive impairment attributable to cardiovascular risk factors. Participants completed a battery of cognitive tests, including time to complete the Trail Making Test A, and a walking speed test. The incidence of dementia was determined over the 12-year follow-up period. Cox proportional hazards models with delayed entry were used to estimate the cumulative risk of dementia and were adjusted for sex, education, and ApoE4 genotype.
RESULTS: Mean age of participants was 74.0 years (SD 4.8). Over the 12-year follow-up, 203 participants developed dementia. GS and PS were both independent predictors of incident all-cause dementia after 12 years of follow-up. For a one SD increase of either GS or PS, the hazard ratio (HR) for Alzheimer's disease was 1.2 (95% CI = 1.02-1.32) and 1.4 (95% CI = 1.2-1.61), respectively; whereas for incident vascular dementia, the HR was 1.3 (95% CI = 1.05-1.71) and 1.5 (95% CI = 1.16-2.08), respectively. No significant interaction between GS and PS was observed.
CONCLUSIONS: In older French people aged 65+, our findings showed that both low GS and PS were independently associated with risk of incident Alzheimer's disease and vascular dementia.

Entities:  

Keywords:  Dementia; elderly; epidemiology; gait speed; psychomotor speed; vascular process

Mesh:

Year:  2017        PMID: 28869468     DOI: 10.3233/JAD-170267

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

1.  Targeted Metabolomics Shows Low Plasma Lysophosphatidylcholine 18:2 Predicts Greater Decline of Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging.

Authors:  Marta Gonzalez-Freire; Ruin Moaddel; Kai Sun; Elisa Fabbri; Pingbo Zhang; Mohammed Khadeer; Norman Salem; Luigi Ferrucci; Richard D Semba
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-01-01       Impact factor: 6.053

2.  Functional Balance and Gait Characteristics in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Authors:  Emad Al-Yahya; Maha T Mohammad; Jennifer Muhaidat; Saddam Al Demour; Dania Qutishat; Lara Al-Khlaifat; Rasha Okasheh; Sophie Lawrie; Patrick Esser; Helen Dawes
Journal:  Am J Mens Health       Date:  2019 May-Jun

3.  Gait speed and body mass index: Results from the AMI study.

Authors:  Maturin Tabue-Teguo; Karine Perès; Nadine Simo; Mélanie Le Goff; Mario Ulises Perez Zepeda; Catherine Féart; Jean-François Dartigues; Hélène Amieva; Matteo Cesari
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

4.  Gait speed, cognition and falls in people living with mild-to-moderate Alzheimer disease: data from NILVAD.

Authors:  Adam H Dyer; Brian Lawlor; Sean P Kennelly
Journal:  BMC Geriatr       Date:  2020-03-30       Impact factor: 3.921

5.  Normative Data for the Symbol Digit Modalities Test in Older White Australians and Americans, African-Americans, and Hispanic/Latinos.

Authors:  Joanne Ryan; Robyn L Woods; Carlene J Britt; Anne M Murray; Raj C Shah; Christopher M Reid; Rory Wolfe; Mark R Nelson; Suzanne G Orchard; Jessica E Lockery; Ruth E Trevaks; Elsdon Storey
Journal:  J Alzheimers Dis Rep       Date:  2020-08-04

6.  Specific lysophosphatidylcholine and acylcarnitine related to sarcopenia and its components in older men.

Authors:  Li Meng; Ruiyue Yang; Daguang Wang; Wenbin Wu; Jing Shi; Ji Shen; Yamin Dang; Guoqing Fan; Hong Shi; Jun Dong; Huan Xi; Pulin Yu
Journal:  BMC Geriatr       Date:  2022-03-25       Impact factor: 3.921

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.